Dr Javier Cortes received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996. He continued his studies at the University of Navarra, specializing in Medical Oncology at the Clínica Universitaria de Navarra, where he continued as Assistant in the Department of Oncology from 2002. He was Associate Professor of Oncology in the Faculty of Medicine at the University of Navarra during that period. Dr Cortés was awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. From June 2003 to July 2015, he has worked in the Department of Medical Oncology at the Hospital Vall d'Hebron, Barcelona, where he has been Coordinator of the Teaching and Training Programme for Residents in Oncology and Senior Specialist in the Area of Breast Cancer with a special interest in New Drug Development. Dr Cortés was the Head of the Breast Cancer Program and the Melanoma Unit from July 2006 to August 2015. From September 2015, he has been Head of the Breast Cancer and Gynecological Tumors at Ramon y Cajal University Hospital in Madrid and Clinical Investigator of the Breast Cancer Research Program at Vall d’Hebron Institute of Oncology.
In addition to his medical specialties, he has two masters’ degree in ‘Medical Direction and Clinical Management’ from the Universidad Nacional de Educación a Distancia (UNED) and ‘Research methodology in Health Sciences’ from the Universidad Autonoma de Barcelona as well as a degree in ‘Statistics in Health Sciences’ from the Universidad Autonoma de Barcelona.
Dr Cortes is the author of more than 140 publications, especially about breast tumours and new drugs, and more than 300 communications at different conferences. He actively participates in the development of numerous national and international clinical investigations, especially in relation to drugs directed against molecular targets and new chemotherapy agents, and he is an ad hoc reviewer of various oncology journals.
Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO) and a member of the Scientific Committee of the European Society of Medical Oncology.